Anti-HIV drugs allow immune system to rebound, fight CMV.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000191:economics / Q000276:immunology*; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D003362:Cost-Benefit Analysis; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy / Q000191:economics / Q000276:immunology*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D007107:Immune System; D016896:Treatment Outcome
D019380:Anti-HIV Agents